MX2016009667A - Crystal form a of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same. - Google Patents
Crystal form a of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same.Info
- Publication number
- MX2016009667A MX2016009667A MX2016009667A MX2016009667A MX2016009667A MX 2016009667 A MX2016009667 A MX 2016009667A MX 2016009667 A MX2016009667 A MX 2016009667A MX 2016009667 A MX2016009667 A MX 2016009667A MX 2016009667 A MX2016009667 A MX 2016009667A
- Authority
- MX
- Mexico
- Prior art keywords
- crystal form
- monobenzoate
- compound
- preparation
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C07C63/08—Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
The present invention belongs to the field of preparing pharmaceutical compounds, in particular relates to a crystal form a of compound A monobenzoate, which is a dipeptidase-IV inhibitor, and a preparation method thereof, and a pharmaceutical composition comprising the crystal form.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410037009 | 2014-01-24 | ||
PCT/CN2015/071525 WO2015110077A1 (en) | 2014-01-24 | 2015-01-26 | Crystal form α of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016009667A true MX2016009667A (en) | 2017-02-28 |
MX366651B MX366651B (en) | 2019-07-17 |
Family
ID=53680849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016009667A MX366651B (en) | 2014-01-24 | 2015-01-26 | Crystal form alpha of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same. |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN104803971B (en) |
BR (1) | BR112016017087B1 (en) |
MX (1) | MX366651B (en) |
RU (1) | RU2677660C2 (en) |
WO (1) | WO2015110077A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106349216B (en) * | 2015-07-15 | 2020-09-11 | 深圳信立泰药业股份有限公司 | Crystal form alpha of compound A, preparation method thereof and pharmaceutical composition containing crystal form |
CN106349215B (en) * | 2015-07-15 | 2022-02-08 | 深圳信立泰药业股份有限公司 | Amorphous form of compound A benzoate, preparation method thereof and pharmaceutical composition containing amorphous form |
WO2018219295A1 (en) * | 2017-05-31 | 2018-12-06 | 深圳信立泰药业股份有限公司 | Deuterated 1,2,4-triazine derivatives of dipeptidyl peptidase iv inhibitor |
CN109692164A (en) * | 2017-10-20 | 2019-04-30 | 深圳信立泰药业股份有限公司 | Compound A or the pharmaceutical composition of its salt and preparation method thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1828192B1 (en) * | 2004-12-21 | 2014-12-03 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
JP5122462B2 (en) * | 2005-09-16 | 2013-01-16 | 武田薬品工業株式会社 | Dipeptidyl peptidase inhibitor |
TW200838536A (en) * | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
FR2933979B1 (en) * | 2008-07-15 | 2012-08-24 | Pf Medicament | TRIAZINE AND URACIL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPY |
CA2784799C (en) * | 2009-12-30 | 2014-06-10 | Shanghai Fochon Pharmaceutical Co Ltd | Certain dipeptidyl peptidase inhibtors |
CA2798591A1 (en) * | 2010-05-12 | 2011-11-17 | Mapi Pharma Limited | Polymorphs of alogliptin benzoate |
CN103172615A (en) * | 2013-03-29 | 2013-06-26 | 山东罗欣药业股份有限公司 | Benzoic acid alogliptin crystal form compound |
-
2015
- 2015-01-23 CN CN201510033908.7A patent/CN104803971B/en active Active
- 2015-01-26 BR BR112016017087-3A patent/BR112016017087B1/en active IP Right Grant
- 2015-01-26 MX MX2016009667A patent/MX366651B/en active IP Right Grant
- 2015-01-26 WO PCT/CN2015/071525 patent/WO2015110077A1/en active Application Filing
- 2015-01-26 RU RU2016134404A patent/RU2677660C2/en active
Also Published As
Publication number | Publication date |
---|---|
BR112016017087A8 (en) | 2018-04-17 |
BR112016017087B1 (en) | 2022-12-27 |
RU2677660C2 (en) | 2019-01-18 |
BR112016017087A2 (en) | 2017-08-08 |
CN104803971A (en) | 2015-07-29 |
CN104803971B (en) | 2021-11-30 |
WO2015110077A1 (en) | 2015-07-30 |
RU2016134404A (en) | 2018-03-01 |
MX366651B (en) | 2019-07-17 |
RU2016134404A3 (en) | 2018-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015207757A8 (en) | N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | |
MX2017004200A (en) | Heteroaryl compounds as btk inhibitors and uses thereof. | |
MX2017006266A (en) | Heteroaryl compounds as irak inhibitors and uses thereof. | |
EP3060041A4 (en) | Prostacyclin compounds, compositions and methods of use thereof | |
MX2018003280A (en) | Antifungal compound process. | |
EP3082819A4 (en) | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith | |
MX2019015744A (en) | Pharmaceutical compositions. | |
HK1232229A1 (en) | Novel compound of 4-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof 4- | |
MX2020001756A (en) | Benzoquinolone inhibitors of vmat2. | |
EA201691363A1 (en) | STABILIZED SILICATE COMPOSITIONS AND THEIR APPLICATION AS ANTI-PERSPIRENT COMPOSITIONS | |
NZ732402A (en) | Nitrification inhibitor compositions and methods for preparing the same | |
MX365494B (en) | Antifungal compound process. | |
MX2016012053A (en) | Antifungal compound process. | |
PH12017500737B1 (en) | Kcnq2-5 channel activator | |
EP3232790A4 (en) | Mixotrophic chlorella-based composition, and methods of its preparation and application to plants | |
MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
MX2020009444A (en) | Low dose oral pharmaceutical composition of isotretinoin. | |
EP3241824A4 (en) | Trifluoroacethydrazide compound as well as preparation method therefor and application thereof in preparing medicament | |
MX2016009667A (en) | Crystal form a of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same. | |
GEP20196974B (en) | A novel crystalline form of a benzimidazole derivative and a preparation method thereof | |
GEP20217236B (en) | Composition comprising pentose and polyphenolic compound | |
MX2015016603A (en) | Corticosteroid compositions. | |
BR112015031820A2 (en) | compound, pharmaceutical composition, intermediate, process for preparing a compound and methods | |
MX2017007931A (en) | Novel crystal forms of the monosodium salt of foramsulfuron. | |
EP3118207A4 (en) | Inclusion compound of 3',5'-cyclicdiadenylic acid, and method for producing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |